Loading...

mosque
partly-cloudy
°C,

EU set to back Novavax Covid vaccine

December 20, 2021 / 9:00 AM
Image for the title: EU set to back Novavax Covid vaccine
download-img
Swabs from patients participating in the Novavax phase 3 Covid-19 clinical vaccine trial await testing at the UW Medicine Retrovirology Lab at ...
Sharjah24 – AFP: The EU's drug regulator will decide Monday whether to approve a Covid jab by Novavax, which uses a more conventional technology that the US biotech firm hopes will reduce vaccine hesitancy.
Novavax's jab, a protein-based vaccine of the kind used around the world to protect against many childhood illnesses, would be the fifth coronavirus shot authorised for the European Union.

Approval would also be a boost for the Maryland company, whose jab has been plagued by delays.

The European Medicines Agency (EMA) said its human medicines committee would hold an extraordinary meeting to decide on Novavax on Monday, and "will communicate the outcome".

The EU has already signed a deal to buy up to 200 million doses of the two-shot vaccine pending approval by the Amsterdam-based watchdog.

Novavax says its vaccine showed 90.4 percent efficacy against Covid-19 in a North American trial.

Chief executive Stanley Erck said the firm "looks forward to providing an additional vaccine option in Europe, built on a proven, well-understood technology platform".

The vaccine "may help address major obstacles to global vaccination, including global distribution challenges and vaccine hesitancy", Erck added.

All vaccines work by teaching the body's immune system to attack the coronavirus, but they do it in different ways.

Novavax's so-called protein subunit technology is already tried and tested, having been used for decades to vaccinate people against diseases including hepatitis B and whooping cough.

It also means it does not have to be stored in ultra-low temperatures, potentially giving it a logistical edge over some other jabs.
December 20, 2021 / 9:00 AM

Related Topics

More on this Topic

Rotate For an optimal experience, please
rotate your device to portrait mode.